For Immediate Release
Contact: mktgcomm@tams.com

TOSHIBA AMERICA MEDICAL SYSTEMS ANNOUNCES 510(K) CLEARANCE FOR INFINIX VC-i SYSTEM WITH 12X16 INCH FLAT PANEL DETECTOR

New High Resolution FPD Represents Next Generation of Diagnostic and Interventional Imaging

RSNA Booth # 7114 (North Building, Hall B)

CHICAGO, Nov. 22, 2005 – Furthering the advancement of diagnostic imaging technologies designed to deliver exceptional clinical performance, Toshiba America Medical Systems, Inc. (TAMS) today announced the U.S. Food and Drug Administration’s 510(k) clearance of its dedicated vascular system, the Infinix VC-i with Large Field of View (LFOV) Flat Panel Detector (FPD).  The Infinix VC-i system with LFOV FPD is Toshiba's newest angiography platform, featuring state-of-the-art technology for vascular exams and interventional procedures. 

The Infinix VC-i system with LFOV FPD will be exhibited for healthcare professionals in Toshiba’s booth at the Radiological Society of North America’s (RSNA) annual meeting held Nov. 27-Dec. 2 at McCormick Place in Chicago (Booth #7114, North Building, Hall B). 

“The addition of the LFOV FPD to our VC-i platform raises the bar for next generation diagnostic and interventional imaging,” said Don Volz, director, Vascular X-ray Business Unit, TAMS.  “The new FPD provides superior imaging capabilities for patients of all sizes.   This is yet another demonstration of Toshiba’s commitment to designing systems for exceptional clinical performance without compromising patient comfort and care.”

The Infinix VC-i’s new LFOV FPD technology streamlines workflow through an all-digital system for incredibly clear imaging and highly efficient vascular exams.  The system provides distortion-free imaging with uniform brightness plus advanced technologies, including a powerful digital acquisition, processing, and storage system—providing immediate access to images and cost-effective archiving. 

Also available is Zoom fluoro, 3-D angio capabilities and exceptional C-arm motion capable of unique lateral coverage to ensure smooth operation during procedures.

Other system features include dose management functions, which ensure high-quality images at the lowest dose; easy-to-use tableside controls; flexible tabletop design; and a liquid metal X-ray tube with a high heat capacity to eliminate waiting for tube cooling during long exams.  The LFOV FPD also is available as an easy field-upgradeable component to existing Infinix VC-i systems.

For more information about the Infinix-i series of vascular X-ray systems, TAMS and its wide range of medical imaging products, please visit www.medical.toshiba.com.

About Toshiba
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States.  Toshiba Medical Systems Corporation, an independent group company of Toshiba Corporation, is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, X-ray, Ultrasound, Nuclear Medicine, MRI and information systems.  Toshiba Corporation is a leader in information and communications systems, electronic components, consumer products, and power systems.  Toshiba has approximately 161,000 employees worldwide and annual sales of $53 billion. 

Infinix^TM is a trademark of Toshiba Medical Systems Corporation.